|
Volumn 38, Issue 11, 1997, Pages 1778-1780
|
A perspective on decision analysis modeling as it relates to sestamibi imaging of nonpalpable breast abnormalities.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DIAGNOSTIC AGENT;
METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;
RADIOPHARMACEUTICAL AGENT;
BIOPSY;
BREAST TUMOR;
COMPUTER SIMULATION;
COST BENEFIT ANALYSIS;
DECISION SUPPORT SYSTEM;
FEMALE;
HUMAN;
NOTE;
PATHOLOGY;
SCINTISCANNING;
SENSITIVITY AND SPECIFICITY;
BIOPSY;
BREAST NEOPLASMS;
COMPUTER SIMULATION;
COST-BENEFIT ANALYSIS;
DECISION SUPPORT TECHNIQUES;
FEMALE;
HUMANS;
RADIOPHARMACEUTICALS;
SENSITIVITY AND SPECIFICITY;
TECHNETIUM TC 99M SESTAMIBI;
|
EID: 0031279712
PISSN: 01615505
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (4)
|
References (0)
|